Carl Weissman Executive Profile

haga-aa8xuq.blogspot.com
In addition, he is currently serving as the Presidenft and CEOof Accelerator, a joint investment vehicle backed by six top-tier venture capitakl investors including OVP investing in and then managing emerging biotechnologh companies. Mr. Weissman led the formation of Acceleratorfin 2003. Accelerator has facilitatefd Series Ainvestments in, and is managinv the operations of, three OVP portfolio companies Homestead Allozyne, and Seredigm. In Accelerator facilitated the initial investment in and managemengof VLST, another OVP company which garnered a $55M Seriews B investment in 2006 (co-led by Prior to joining OVP, Mr. Weissman was a Venture Partne atMPM Capital.
While a Venture Partner at MPM, Mr. Weissma was the President and CEO of a Cambridge, MA, human genetics Mr. Weissman led the 2003 merger of Centagenetix with Elixir which catalyzed a greaterthan $40M Series B financing in the combined company, where he remained on the Board until early 2005. Prio to joining MPM, he spentf six years at Inc., where he held a numbedr of positions, culminating as the head of both Financwe andBusiness Development.
**All Executive profile data provided byDow